These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 7779245)
1. The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Eriksson E; Hedberg MA; Andersch B; Sundblad C Neuropsychopharmacology; 1995 Apr; 12(2):167-76. PubMed ID: 7779245 [TBL] [Abstract][Full Text] [Related]
2. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial. Sundblad C; Hedberg MA; Eriksson E Neuropsychopharmacology; 1993 Sep; 9(2):133-45. PubMed ID: 8216696 [TBL] [Abstract][Full Text] [Related]
3. A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side-effects during ten cycles of treatment. Sundblad C; Wikander I; Andersch B; Eriksson E Eur Neuropsychopharmacol; 1997 Aug; 7(3):201-6. PubMed ID: 9213079 [TBL] [Abstract][Full Text] [Related]
5. Short onset of action of a serotonin reuptake inhibitor when used to reduce premenstrual irritability. Landén M; Erlandsson H; Bengtsson F; Andersch B; Eriksson E Neuropsychopharmacology; 2009 Feb; 34(3):585-92. PubMed ID: 18596686 [TBL] [Abstract][Full Text] [Related]
6. Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Atkinson JH; Slater MA; Wahlgren DR; Williams RA; Zisook S; Pruitt SD; Epping-Jordan JE; Patterson TL; Grant I; Abramson I; Garfin SR Pain; 1999 Nov; 83(2):137-45. PubMed ID: 10534584 [TBL] [Abstract][Full Text] [Related]
7. Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder. Landén M; Nissbrandt H; Allgulander C; Sörvik K; Ysander C; Eriksson E Neuropsychopharmacology; 2007 Jan; 32(1):153-61. PubMed ID: 17035933 [TBL] [Abstract][Full Text] [Related]
9. A double-blind study comparing paroxetine and maprotiline in depressed outpatients. Szegedi A; Wetzel H; Angersbach D; Dunbar GC; Schwarze H; Philipp M; Benkert O Pharmacopsychiatry; 1997 May; 30(3):97-105. PubMed ID: 9211571 [TBL] [Abstract][Full Text] [Related]
10. Response to treatment in minor and major depression: results of a double-blind comparative study with paroxetine and maprotiline. Szegedi A; Wetzel H; Angersbach D; Philipp M; Benkert O J Affect Disord; 1997 Sep; 45(3):167-78. PubMed ID: 9298430 [TBL] [Abstract][Full Text] [Related]
11. Paroxetine treatment of mood disorders in women: premenstrual dysphoric disorder and hot flashes. Yonkers KA Psychopharmacol Bull; 2003; 37 Suppl 1():135-47. PubMed ID: 14566208 [TBL] [Abstract][Full Text] [Related]
12. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study. Wang M; Hammarbäck S; Lindhe BA; Bäckström T Acta Obstet Gynecol Scand; 1995 Nov; 74(10):803-8. PubMed ID: 8533564 [TBL] [Abstract][Full Text] [Related]
13. Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria. Eriksson E Int Clin Psychopharmacol; 1999 May; 14 Suppl 2():S27-33. PubMed ID: 10471170 [TBL] [Abstract][Full Text] [Related]
14. Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled trial in Canadian women. Steiner M; Ravindran AV; LeMelledo JM; Carter D; Huang JO; Anonychuk AM; Simpson SD J Clin Psychiatry; 2008 Jun; 69(6):991-8. PubMed ID: 18517289 [TBL] [Abstract][Full Text] [Related]
15. A double-blind, multicentre study of paroxetine and maprotiline in major depression. Schnyder U; Koller-Leiser A Can J Psychiatry; 1996 May; 41(4):239-44. PubMed ID: 8726790 [TBL] [Abstract][Full Text] [Related]
16. Paroxetine as a treatment for premenstrual dysphoric disorder. Yonkers KA; Gullion C; Williams A; Novak K; Rush AJ J Clin Psychopharmacol; 1996 Feb; 16(1):3-8. PubMed ID: 8834412 [TBL] [Abstract][Full Text] [Related]